Equities Archives - Page 3 of 1061

2 minute read

GMS Surpasses Q4 Sales Expectations, Faces Near-Term Challenges in Wallboard And Steel Margins

June 20, 10:53 AM

GMS Inc. reported strong Q4 net sales of $1.413B, with organic growth of 4%, driven by volume growth. Adjusted EPS missed consensus, but EBITDA and cash flow remained solid.

GMS

1 minute read

Cheche Group Rides High With NIO Partnership, Eyes Expansion: Details

By Nabaparna Bhattacharya

June 20, 10:35 AM

Cheche Group's NEV insurance prospects soar with NIO partnership, aiming to revolutionize digital insurance management in China's EV market.

CCG

1 minute read

Tesla’s Top Rival, BYD’s Yuan Family Hits 1M Sales Milestone As SUV Lineup Drives NEV Success: Report

By Nabaparna Bhattacharya

June 20, 10:33 AM

BYD's Yuan family achieves 1 million sales milestone, highlighting success in NEV market with SUV lineup, amidst ongoing model expansions.

BYDDF

2 minute read

PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder

By Vandana Singh

June 20, 10:09 AM

PTC Therapeutics released interim results from its Phase 2 PIVOT-HD study on PTC518 for Huntington's disease. The FDA has lifted the partial clinical hold on the program.

PTCT

2 minute read

Joby Aviation Opens Slightly Lower After FAA Gives Nod To Air-Taxi Software

By Benzinga Neuro

June 20, 10:03 AM

Joby Aviation intends to utilize ElevateOS for its air taxi operations and make it available to select partners who purchase their aircraft.

JOBY

2 minute read

Recreation Products Maker Winnebago Struggles In Q3 With Lower Earnings, But New Product Launches Offer Hope: Details

By Nabaparna Bhattacharya

June 20, 9:56 AM

Winnebago Industries shares drop post-Q3 earnings miss with lower revenues and decreased gross profit margins amid challenging market conditions.

WGO

2 minute read

What’s Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday?

By Vandana Singh

June 20, 9:43 AM

Tempest Therapeutics shares drop 13% to $2.48 on Thursday despite promising new data from its Phase 1b/2 study. The study shows a six-month survival improvement in hepatocellular carcinoma patients using TPST-1120 combined with atezolizumab and bevacizumab.

TPST

2 minute read

Honeywell Swoops In To Acquire CAES For $1.9B, Boosts Defense Business

By Lekha Gupta

June 20, 9:22 AM

Honeywell (NASDAQ: HON) to acquire CAES Systems Holdings LLC from Advent International for $1.9B. Deal expected to boost EPS and expand defense solutions.

CARR

2 minute read

Sasol Soars On Pipeline Payday: Court Awards $344M in Tariff Dispute

By Lekha Gupta

June 20, 9:22 AM

The litigation between Sasol and Transnet spans years. The remaining issues in the litigation went to trial in South Africa.

SSL

2 minute read

Jobless Claims Exceed Estimates, Philly Fed Index Declines, Housing Starts And Permits Fall Sharply: Thursday’s Economic Digest

By Piero Cingari

June 20, 9:12 AM

Economic data shows mixed results on Thursday, with higher jobless claims and weak housing starts, but positive future indicators. Market reactions were slight.

QQQ